drugset / Trial / NCT00718120
Immunogenicity and Safety Study of GSK Biologicals' Fluviral® (2008 - 2009 Season) in Adults Over 18 Years
Non-randomizedParallel-groupOpen-labelPrevention
Summary
This study will evaluate the immunogenicity and safety of GSK Biologicals' Trivalent split virion influenza vaccine Fluviral for the 2008-2009 season in adults over the age of 18.
Timeline
- Start
- 2008-07-18
- Primary completion
- 2008-08-09
- Completion
- 2008-08-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluviral | Vaccine | — | Intramuscular |
Indications
No indication recorded.